65338-95-6Relevant articles and documents
DIAGNOSTIC AGENT FOR THERAPEUTIC EFFECT ON CANCER
-
Paragraph 0122; 0123, (2016/09/26)
The present invention provides a diagnostic agent for a therapeutic effect on cancer, containing a compound represented by formula (1-0). (In formula (1-0), R represents —O(CH2)n—, —O(CH2)nOC2H4—, —CH2O(CH2)n—, or —CH2O(CH2)nOC2H4—, n represents an integer of 1 to 5, and Q1 represents F or —OCH3.)
COMPOUND SUITABLE FOR DETECTION OF MITOCHONDRIAL COMPLEX-1
-
Paragraph 0109-0111, (2015/09/22)
Provided is a compound represented by formula (1-0): wherein in formula (1-0), R represents —O(CH2)n—, —O(CH2)nOC2H4—, —CH2O(CH2)n— or —CH2O(CHs
Neutral Ligands with Surfactant-Type Structure - Synthesis, Complexation, and Ion Transfer
Weber, Edwin
, p. 770 - 801 (2007/10/02)
New lipophilic neutral ligands which combine crown ether and podand characteristics with structural features of surfactants (cf. formulas 1-12, 16-26) were synthesized.Their complexation behaviour was studied, their solid-to-liquid and liquid-to-liquid phase transfer properties as well as their efficiency in ion transport across a liquid model membrane.Crystalline stoichiometric complexes of the cycles 2a-4a and of 3e with NaSCN, Ba(SCN)2, and BaI2 can be isolated.Among the noncyclic representatives a crystalline complex is obtained only from 11 with BaI2.The ligand 8d behaves in aqueous solution as a typical surfactant showing micelle formation and cloud point.